European Medicines Agency: the gem London will lose and 11 states want


A woman walks in front of London's financial district Canary Wharf in London, Britain, 14 December 2016. Besides an exodus of bankers, Britain will also lose a huge cluster of researchers and R&D professionals linked to the drug industry

While Britain kills a competitive advantage in the pharmaceutical industry, other states are stepping up their game

The European Medicines Agency (EMA) is leaving London and at least eleven EU member states are placing their bids to take it on. Some have better chances than others.
The EU Agency was begun operating in London in 1995, and its mission is to supervise research and monitor the safety of medicinal products across the EU’s Single Market. Except Britain is leaving the EU and, it transpires, the Single European Market.

In a statement published in July 2016, the agency made clear it accept...

This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now